The New and Old Europe: East-West Split in Pharmaceutical Spending.
about
Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of LiteratureDisability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020.Trends and Patterns of Disparities in Oral Cavity and Pharyngeal Cancer in Serbia: Prevalence and Economic Consequences in a Transitional CountryLong Term Dental Work Force Build-Up and DMFT-12 Improvement in the European Region.Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia.Global pharmaceutical regulation: the challenge of integration for developing states.Commentary: Do health care workforce, population, and service provision significantly contribute to the total health expenditure? An econometric analysis of Serbia.Critical Appraisal of Reimbursement List in Bosnia and Herzegovina.Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025.The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change.Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study.Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications.High Out-of-Pocket Health Spending in Countries With a Mediterranean Connection.Cold War Legacy in Public and Private Health Spending in Europe
P2860
Q28073025-3B857BE0-D2FA-429F-A779-BA0E0EB68096Q30378272-C2A383A8-7BDC-4855-B6D4-562C28247B47Q33804329-FEF9802E-B8EA-4CB7-93D3-7F8EC90614E9Q36605761-EDA20BF8-D054-4C3D-A504-AD5714483E8CQ37297978-06D65E98-8524-4FE3-8E44-DA01DB39DC61Q37335934-AD584E58-4A29-4C19-8299-DEBBA80DD2A1Q37522901-8BA80B48-4699-425E-B4B3-F2DCA7EC5D96Q37625330-9912F54B-BBBC-494D-864B-628FDAF5D8B8Q37707280-976FA3FD-8C66-4E40-9563-1A5850B86FE7Q38816604-E30515A9-8B4E-4716-BCB9-6E9F5C65203EQ44697952-33BEE74E-5C50-4629-BB69-CE2037FA4727Q45897723-AF7341C8-943C-4BEC-AF01-9CDCF30DCAC8Q55078654-0EDD20A7-C895-4D54-9241-71BF50EE3844Q55354278-E388EEC3-B638-4EEC-A69D-6AF34FB583F8Q58799048-F9B88FE5-9490-4D10-A83C-6B8C4FDAA0E4
P2860
The New and Old Europe: East-West Split in Pharmaceutical Spending.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@ast
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@en
type
label
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@ast
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@en
prefLabel
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@ast
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@en
P2860
P50
P356
P1476
The New and Old Europe: East-West Split in Pharmaceutical Spending.
@en
P2093
Marija Lazarevic
P2860
P356
10.3389/FPHAR.2016.00018
P577
2016-02-09T00:00:00Z